|
|
|
|
| LEADER |
03313nam a22004935i 4500 |
| 001 |
978-3-319-24097-8 |
| 003 |
DE-He213 |
| 005 |
20210618090015.0 |
| 007 |
cr nn 008mamaa |
| 008 |
160513s2016 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319240978
|9 978-3-319-24097-8
|
| 024 |
7 |
|
|a 10.1007/978-3-319-24097-8
|2 doi
|
| 050 |
|
4 |
|a RE1-994
|
| 072 |
|
7 |
|a MJQ
|2 bicssc
|
| 072 |
|
7 |
|a MED063000
|2 bisacsh
|
| 072 |
|
7 |
|a MJQ
|2 thema
|
| 082 |
0 |
4 |
|a 617.7
|2 23
|
| 245 |
1 |
0 |
|a Anti-Angiogenic Therapy in Ophthalmology
|h [electronic resource] /
|c edited by Andreas Stahl.
|
| 250 |
|
|
|a 1st ed. 2016.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
| 300 |
|
|
|a X, 193 p. 26 illus., 23 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Essentials in Ophthalmology,
|x 1612-3212
|
| 505 |
0 |
|
|a Retinal Vascular Development -- Retinopathy of Prematurity -- Anti-Vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors -- AREDS Supplementation and the Progression Towards Neovascular Exudative AMD -- VEGF-Inhibition in Macular Telangiectasia Type 2 -- Diabetic Retinopathy -- Retinal Vein Occlusion -- Pharmacokinetics of Intravitreally Applied VEGF Inhibitors -- Neovascular Glaucoma -- Corneal Neovascular Diseases -- Anti‐Angiogenic Gene Therapy - Basic Science and Challenges for Translation into the Clinic.
|
| 520 |
|
|
|a This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.
|
| 650 |
|
0 |
|a Ophthalmology.
|
| 650 |
|
0 |
|a Angiology.
|
| 650 |
1 |
4 |
|a Ophthalmology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H44004
|
| 650 |
2 |
4 |
|a Angiology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H33010
|
| 700 |
1 |
|
|a Stahl, Andreas.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer Nature eBook
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319240954
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319240961
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319795805
|
| 830 |
|
0 |
|a Essentials in Ophthalmology,
|x 1612-3212
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-24097-8
|
| 912 |
|
|
|a ZDB-2-SME
|
| 912 |
|
|
|a ZDB-2-SXM
|
| 950 |
|
|
|a Medicine (SpringerNature-11650)
|
| 950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|
